Inflammatory dendritic cells restrain CD11b+CD4+CTLs via CD200R in human NSCLC

被引:2
作者
Lin, Mingjie [1 ,2 ]
Chen, Di [2 ,3 ]
Shao, Zheyu [1 ,2 ]
Liu, Qinyuan [1 ,2 ]
Hao, Zhixing [1 ,2 ]
Xin, Zhongwei [1 ,2 ]
Chen, Yongyuan [1 ,2 ]
Wu, Wenxuan [2 ,4 ]
Chen, Xiaoke [1 ,2 ]
He, Teng [2 ,5 ]
Wu, Dang [2 ]
Wu, Pin [1 ,2 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Thorac Surg, Hangzhou 310009, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Key Lab Tumor Microenvironm & Immune Therapy Zheji, Hangzhou, 310009, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Radiat Oncol, Hangzhou 310009, Peoples R China
[4] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Gastrointestinal Surg, Hangzhou 310009, Peoples R China
[5] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Infect Dis, Hangzhou 310009, Peoples R China
基金
中国国家自然科学基金;
关键词
CD4(+) T-CELLS; RESIDENT MEMORY; LYMPHOCYTES; EXPRESSION; TISSUE; MELANOMA; HELPER;
D O I
10.1016/j.celrep.2024.113767
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD4+ cytotoxic T lymphocytes (CD4+ CTLs) are suggested to play a crucial role in inflammatory diseases, including cancer, but their characteristics in human non -small cell lung cancer (NSCLC) remain unknown. Here, using the cell surface marker CD11b, we identify CD11b+CD4+ CTLs as a cytotoxic subset of CD4+ T cells in multiple tissues of NSCLC patients. In addition, tumor -infiltrating CD11b+CD4+ CTLs show a dysfunctional phenotype with elevated expression of CD200 receptor (CD200R), a negatively immunomodulatory receptor. CD4+ regulatory T (Treg) cells restrain the anti -tumor role of CD11b+CD4+ CTLs via CD200. Mechanistically, inflammatory dendritic cells promote the CD200R expression of CD11b+CD4+ CTLs by secreting interleukin-1b (IL -1b). Finally, we demonstrate that CD200 blockade can revive the tumor -killing role of CD11b+CD4+ CTLs and prolong the survival of tumor -bearing mice. Taken together, our study identifies CD11b+CD4+ CTLs in NSCLC with decreased cytotoxicity that can be reinvigorated by CD200 blockade, suggesting that targeting CD200 is a promising immunotherapy strategy in NSCLC.
引用
收藏
页数:22
相关论文
共 50 条
[41]   Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures [J].
Sun, Q ;
Burton, RL ;
Lucas, KG .
BLOOD, 2002, 99 (09) :3302-3309
[42]   CD4 Helper and CD8 Cytotoxic T Cell Differentiation [J].
Taniuchi, Ichiro .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36, 2018, 36 :579-601
[43]   A novel CD4+CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves' orbitopathy [J].
Wang, Yue ;
Chen, Ziyi ;
Wang, Tingjie ;
Guo, Hui ;
Liu, Yufeng ;
Dang, Ningxin ;
Hu, Shiqian ;
Wu, Liping ;
Zhang, Chengsheng ;
Ye, Kai ;
Shi, Bingyin .
CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (03) :735-745
[44]   S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β [J].
Weichand, Benjamin ;
Popp, Ruediger ;
Dziumbla, Sarah ;
Mora, Javier ;
Strack, Elisabeth ;
Elwakeel, Eiman ;
Frank, Ann-Christin ;
Scholich, Klaus ;
Pierre, Sandra ;
Syed, Shahzad N. ;
Olesch, Catherine ;
Ringleb, Julia ;
Oeren, Bilge ;
Doering, Claudia ;
Savai, Rajkumar ;
Jung, Michaela ;
von Knethen, Andreas ;
Levkau, Bodo ;
Fleming, Ingrid ;
Weigert, Andreas ;
Bruene, Bernhard .
JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (09) :2695-2713
[45]   Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma [J].
Xie, Ying ;
Akpinarli, Akguel ;
Maris, Charles ;
Hipkiss, Edward L. ;
Lane, Malcolm ;
Kwon, Eun-Kyung M. ;
Muranski, Pawel ;
Restifo, Nicholas P. ;
Antony, Paul Andrew .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (03) :651-667
[46]   Lineage tracking reveals dynamic relationships of T cells in colorectal cancer [J].
Zhang, Lei ;
Yu, Xin ;
Zheng, Liangtao ;
Zhang, Yuanyuan ;
Li, Yansen ;
Fang, Qiao ;
Gao, Ranran ;
Kang, Boxi ;
Zhang, Qiming ;
Huang, Julie Y. ;
Konno, Hiroyasu ;
Guo, Xinyi ;
Ye, Yingjiang ;
Gao, Songyuan ;
Wang, Shan ;
Hu, Xueda ;
Ren, Xianwen ;
Shen, Zhanlong ;
Ouyang, Wenjun ;
Zhang, Zemin .
NATURE, 2018, 564 (7735) :268-+
[47]   Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma [J].
Zhang, Qiming ;
He, Yao ;
Luo, Nan ;
Patel, Shashank J. ;
Han, Yanjie ;
Gao, Ranran ;
Modak, Madhura ;
Carotta, Sebastian ;
Haslinger, Christian ;
Kind, David ;
Peet, Gregory W. ;
Zhong, Guojie ;
Lu, Shuangjia ;
Zhu, Weihua ;
Mao, Yilei ;
Xiao, Mengmeng ;
Bergmann, Michael ;
Hu, Xueda ;
Kerkar, Sid P. ;
Vogt, Anne B. ;
Pflanz, Stefan ;
Liu, Kang ;
Peng, Jirun ;
Ren, Xianwen ;
Zhang, Zemin .
CELL, 2019, 179 (04) :829-+
[48]   Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer [J].
Zhang, Yuanyuan ;
Chen, Hongyan ;
Mo, Hongnan ;
Hu, Xueda ;
Gao, Ranran ;
Zhao, Yahui ;
Liu, Baolin ;
Niu, Lijuan ;
Sun, Xiaoying ;
Yu, Xiao ;
Wang, Yong ;
Chang, Qing ;
Gong, Tongyang ;
Guan, Xiuwen ;
Hu, Ting ;
Qian, Tianyi ;
Xu, Binghe ;
Ma, Fei ;
Zhang, Zemin ;
Liu, Zhihua .
CANCER CELL, 2021, 39 (12) :1578-+
[49]   Humoral and cellular immune memory to four COVID-19 vaccines [J].
Zhang, Zeli ;
Mateus, Jose ;
Coelho, Camila H. ;
Dan, Jennifer M. ;
Moderbacher, Carolyn Rydyznski ;
Galvez, Rosa Isela ;
Cortes, Fernanda H. ;
Grifoni, Alba ;
Tarke, Alison ;
Chang, James ;
Escarrega, E. Alexandar ;
Kim, Christina ;
Goodwin, Benjamin ;
Bloom, Nathaniel, I ;
Frazier, April ;
Weiskopf, Daniela ;
Sette, Alessandro ;
Crotty, Shane .
CELL, 2022, 185 (14) :2434-+
[50]   Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma [J].
Zhou, Yan ;
Yang, Dong ;
Yang, Qingcheng ;
Lv, Xiaobin ;
Huang, Wentao ;
Zhou, Zhenhua ;
Wang, Yaling ;
Zhang, Zhichang ;
Yuan, Ting ;
Ding, Xiaomin ;
Tang, Lina ;
Zhang, Jianjun ;
Yin, Junyi ;
Huang, Yujing ;
Yu, Wenxi ;
Wang, Yonggang ;
Zhou, Chenliang ;
Su, Yang ;
He, Aina ;
Sun, Yuanjue ;
Shen, Zan ;
Qian, Binzhi ;
Meng, Wei ;
Fei, Jia ;
Yao, Yang ;
Pan, Xinghua ;
Chen, Peizhan ;
Hu, Haiyan .
NATURE COMMUNICATIONS, 2020, 11 (01)